Clinical Trial Imaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Clinical Trial Imaging Market is segmented by Product and Service (Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, Imaging Software), Modality, End User and Geography

Market Snapshot

Clinical Trial Imaging Market Overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.5 %
Clinical Trial Imaging Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The clinical trial imaging market will grow due to the rise in the number of contract research organization, an increase in the R&D spending and growth in the pharmaceutical and biotechnological companies.

With the increasing advancements in science and technology, there has been an increasing growth of pharmaceutical companies across the globe. The rise in the number of pharmaceutical and biotechnology companies is making it imperative for the manufacturers to deliver the best possible drug or medicine to the end-user, as competition is striking the companies. This factor is contributing to the rise of clinical trials as a large number of novel drug discoveries are being done by these companies.

Thus, the rise in the number of drug discoveries is fuelling the demand for implementation of imaging technologies in clinical trials. This is positively affecting the growing number of pharmaceutical and biotechnological companies.

In addition the improvements seen in the overall regulatory framework has also affected the market growth and the acceptance of imaging technologies in clinical trials.

Scope of the Report

As per the scope of the report, clinical trial imaging is now an important part of the research and development process of pharmaceutical and biotechnology industries. The usage of medical imaging is now recognized in clinical trials, to make trials more effective and accurate.

By Product and Service
Trial Design Consulting Services
Read Analysis Services
Operational Imaging Services
Imaging Software
By Modality
Magnetic Resonance Imaging
Computed Tomography
Positron Emission Tomography
Other Modalities
By End-User
Pharmaceutical Companies
Medical Device Manufacturers
Academic and Government Research Institutes
Other End-Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Computed Tomography is Expected to Witness Rapid Growth

Computed tomography is a non-invasive medical procedure that makes use of X-Rays to generate cross-sectional images of the body and provides detailed information for the treatment and examines abnormalities in children and adults.

Computed tomography (CT) segment growth is being attributed to extensive advantages CT offers such as the study of drug activity and screenings for injuries, cancer (tumors), and abnormalities inside the body. Furthermore, the increased funding and investment in the field of clinical research and clinical trials is boosting the segment growth. The large share of this segment is also attributed to the high advantages of CT in screenings for cancer (tumors), injuries.

Clinical Trial Imaging Market key Trends

North America is Anticipated to Dominate the Clinical Trial Imaging Market

North America is found dominating the clinical trial imaging market due to the rising prevalence of chronic diseases combined with increasing geriatric population that is poised to spur the growth of the regional market. Besides this, the advancements in healthcare infrastructure are enabling faster diagnosis and treatment of chronic diseases.

However, the US FDA and other regulatory organizations have also played a leading role in attaining accomplishments of trial registration to date and is likely to be supported in tackling such challenges in the near future. Owing to all these factors, the regional market is projected to maintain its position in the market throughout the forecast period.

Clinical Trial Imaging Market Growth Rate

Competitive Landscape

The key participants of the market studied include Bioclinica Inc, Ixico PLC, Icon PLC, Intrinsic Imaging LLC, Radiant Sage LLC and Parexel International Corporation. These major players are undertaking growth strategies such as new product launches, mergers and acquisitions to retain share and diversify product portfolio.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growth in The Pharmaceutical and Biotechnological Companies

      2. 4.2.2 Rise in Number of Contract Research Organization

      3. 4.2.3 Increase in R&D Spending

    3. 4.3 Market Restraints

      1. 4.3.1 High Implementation Barriers and Costs of Imaging Systems

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product and Service

      1. 5.1.1 Trial Design Consulting Services

      2. 5.1.2 Read Analysis Services

      3. 5.1.3 Operational Imaging Services

      4. 5.1.4 Imaging Software

    2. 5.2 By Modality

      1. 5.2.1 Magnetic Resonance Imaging

      2. 5.2.2 Computed Tomography

      3. 5.2.3 Ultrasound

      4. 5.2.4 Positron Emission Tomography

      5. 5.2.5 X-Ray

      6. 5.2.6 Echocardiography

      7. 5.2.7 Other Modalities

    3. 5.3 By End-User

      1. 5.3.1 Pharmaceutical Companies

      2. 5.3.2 Medical Device Manufacturers

      3. 5.3.3 Academic and Government Research Institutes

      4. 5.3.4 Other End-Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Bioclinica Inc.

      2. 6.1.2 Biomedical Systems Corporation

      3. 6.1.3 Biotelemetry Inc.

      4. 6.1.4 Cardiovascular Imaging Technologies LLC

      5. 6.1.5 Icon PLC

      6. 6.1.6 Intrinsic Imaging LLC

      7. 6.1.7 Ixico PLC

      8. 6.1.8 Parexel International Corporation

      9. 6.1.9 Radiant Sage LLC

      10. 6.1.10 Worldcare Clinical LLC

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Clinical Trial Imaging Market market is studied from 2018 - 2026.

The Clinical Trial Imaging Market is growing at a CAGR of 6.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Bioclinica Inc., Radiant Sage LLC, Biotelemetry Inc., Cardiovascular Imaging Technologies LLC, Icon PLC are the major companies operating in Clinical Trial Imaging Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!